R. Wesley Vosburg M.D. , Abdelrahman Nimeri M.D. , Dan Azagury M.D. , Brandon Grover M.D. , Sabrena Noria M.D. , Pavlos Papasavas M.D. , Jonathan Carter M.D.
{"title":"ASMBS literature review on the treatment of marginal ulcers after metabolic and bariatric surgery","authors":"R. Wesley Vosburg M.D. , Abdelrahman Nimeri M.D. , Dan Azagury M.D. , Brandon Grover M.D. , Sabrena Noria M.D. , Pavlos Papasavas M.D. , Jonathan Carter M.D.","doi":"10.1016/j.soard.2024.10.003","DOIUrl":null,"url":null,"abstract":"<div><div>Marginal ulcers (MUs) encompass a group of mucosal disruptions and subsequent inflammatory changes and their sequala found after Roux-en-Y gastric bypass (RYGB) oneanastomosis gastric bypass (OAGB), and, less commonly, after biliopancreatic diversion with duodenal switch (BPD/DS) or single anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S). Prevalence of MU after RYGB ranges from .6%–16%. This review summarizes the current knowledge about the treatment options available for MU after MBS for providers who treat them.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 1","pages":"Pages 1-8"},"PeriodicalIF":3.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for Obesity and Related Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S155072892400844X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Marginal ulcers (MUs) encompass a group of mucosal disruptions and subsequent inflammatory changes and their sequala found after Roux-en-Y gastric bypass (RYGB) oneanastomosis gastric bypass (OAGB), and, less commonly, after biliopancreatic diversion with duodenal switch (BPD/DS) or single anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S). Prevalence of MU after RYGB ranges from .6%–16%. This review summarizes the current knowledge about the treatment options available for MU after MBS for providers who treat them.
边缘溃疡(MUs)包括一组粘膜破坏和随后的炎症性变化及其后遗症,可在 Roux-en-Y 胃旁路术(RYGB)、单吻合胃旁路术(OAGB)后发现,也可在胆胰转流术伴十二指肠转换术(BPD/DS)或单吻合十二指肠回肠造口术伴袖状胃切除术(SADI-S)后发现,但较少见。RYGB 术后 MU 的发病率在 0.6%-16% 之间。本综述总结了目前有关 MBS 后 MU 治疗方案的知识,供治疗 MU 的医疗人员参考。
期刊介绍:
Surgery for Obesity and Related Diseases (SOARD), The Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities.